{"id":824060,"date":"2025-03-11T07:06:08","date_gmt":"2025-03-11T11:06:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/"},"modified":"2025-03-11T07:06:08","modified_gmt":"2025-03-11T11:06:08","slug":"vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/","title":{"rendered":"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">WATERTOWN, Mass., March  11, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PFZUjWGBK4jla_dX5gdSxdP98ZchKD1iIffL6BEpAxOe7-V1d7T5rrfrp0rlgktly1EAydglU6v_YBLHx2VXuz7vrNL6tBg4HyTJHgTcAEE=\" rel=\"nofollow\" target=\"_blank\">Vigil Neuroscience, Inc.<\/a> (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025, at 9:00 a.m. ET.<\/p>\n<p align=\"justify\">To register for the live webcast, please <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HuF5fI7Tqp8viZPUUBewMLPzXCBSXNOf1-O-3M6goos21rl2mEDLkFkv5y8JIlJ-7cNdA05ZD0VBIKnjGYgIiVzRKTzuos4tdT4OPnejiu9j-ciYqKjVvAlOO5wwU8Xi\" rel=\"nofollow\" target=\"_blank\">click here<\/a>. The webcast will also be available on the Company\u2019s website in the \u201cInvestors\u201d section under <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=igb3t6BnwEAFwIJDCNNjsg0XVxeHUXfAPCXZXc9cDHPrkR4Flfco26dXknH8n1amIaHYNj649ck8aa2GNTVQs7gsWz_EYLVT27gpXZl0XDYoH8QBbwS_SYeLgy2uqtmpMlGJAPw1dWyl62xNeQh72StA98i5zWo7o12AGfMc67c=\" rel=\"nofollow\" target=\"_blank\">\u201cEvents &amp; Presentations<\/a>.\u201d An archived webcast will be available for approximately 90 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Vigil Neuroscience<\/strong>\n      <\/p>\n<p align=\"justify\">Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Vigil is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and their families. Iluzanebart, Vigil\u2019s lead clinical candidate, is a fully human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 (TREM2) in people with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. Vigil is also developing VG-3927, a novel small molecule TREM2 agonist, to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer\u2019s disease (AD).<\/p>\n<p align=\"justify\">\n        <strong>Internet Posting of Information<\/strong>\n      <\/p>\n<p align=\"justify\">Vigil Neuroscience routinely posts information that may be important to investors in the \u201cInvestors\u201d section of its website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5Ad1UfrB99f1N0O6EwkspjTg0wj5h1bvWxPsu2j2rRC81WDdCqQ2Xr6PkP1wbVkHov8jI9hQQt7Nt6rzn5OOReBToOH388TmxX43gwqCpYA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.vigilneuro.com<\/a>. The company encourages investors and potential investors to consult our website regularly for important information about Vigil Neuroscience.<\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Leah Gibson<br \/>Vice President, Investor Relations &amp; Corporate Communications<br \/>Vigil Neuroscience, Inc.<br \/>lgibson@vigilneuro.com<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Megan McGrath<br \/>CTD Comms, LLC<br \/>megan@ctdcomms.com \u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTY4NmZkYWYtMTVkOC00NmFmLThiNTgtYjcwOTU1MWIyODU2LTEyMzQ2NzEtMjAyNS0wMy0xMS1lbg==\/tiny\/Vigil-Neuroscience-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) &#8212; Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025, at 9:00 a.m. ET. To register for the live webcast, please click here. The webcast will also be available on the Company\u2019s website in the \u201cInvestors\u201d section under \u201cEvents &amp; Presentations.\u201d An archived webcast will be available for approximately 90 days following the event. About Vigil Neuroscience Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-824060","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) &#8212; Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025, at 9:00 a.m. ET. To register for the live webcast, please click here. The webcast will also be available on the Company\u2019s website in the \u201cInvestors\u201d section under \u201cEvents &amp; Presentations.\u201d An archived webcast will be available for approximately 90 days following the event. About Vigil Neuroscience Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the &hellip; Continue reading &quot;Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-11T11:06:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum\",\"datePublished\":\"2025-03-11T11:06:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/\",\"name\":\"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=\",\"datePublished\":\"2025-03-11T11:06:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/","og_locale":"en_US","og_type":"article","og_title":"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - Market Newsdesk","og_description":"WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) &#8212; Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that management will participate in a fireside chat at the Stifel 2025 Virtual CNS Forum on Wednesday, March 19, 2025, at 9:00 a.m. ET. To register for the live webcast, please click here. The webcast will also be available on the Company\u2019s website in the \u201cInvestors\u201d section under \u201cEvents &amp; Presentations.\u201d An archived webcast will be available for approximately 90 days following the event. About Vigil Neuroscience Vigil Neuroscience is a clinical-stage biotechnology company focused on developing treatments for both rare and common neurodegenerative diseases by restoring the &hellip; Continue reading \"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-11T11:06:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum","datePublished":"2025-03-11T11:06:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/"},"wordCount":302,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/","name":"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=","datePublished":"2025-03-11T11:06:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MTA4MCM2Nzk2MzUzIzIyMjMxMTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vigil-neuroscience-to-present-at-the-stifel-2025-virtual-cns-forum\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=824060"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/824060\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=824060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=824060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=824060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}